As Ireland faces the formidable challenge of having the Trinity’s research excellence underpins Trinity St James’s second highest rate of new cancer diagnoses in the EU, with success. The institute’s four interconnected research an estimated 44,000 new cases each year, a transformative themes build on existing expertise in Cancer Prevention/ milestone o ers new hope: the Trinity St James’s Early Diagnosis, Molecular Oncology, Cancer Immunology, Cancer Institute has become Ireland’s first accredited and Survivorship, to power the delivery of science-led Comprehensive Cancer Centre (CCC). treatments. Academic Director Professor Maeve Lowery Trinity St James’s joins Europe’s top oncology network through validation by the Organisation of European Cancer Institutes (OECI). This historic designation, announced at St James’s Hospital with Minister for Health Jennifer Carroll MacNeill as guest of honour, places Trinity St James’s alongside renowned institutions like Cambridge noted this framework ‘demonstrates achievements equal to top European centres.’ This academic-clinical integration aligns with St James’s Hospital CEO Professor Mary Day’s vision to establish an Academic Health Science Centre on campus, as part of a network of CCCs that share learning, best practice and innovation. Cancer Research Hospital and Stockholm’s Karolinska Institute. The elevated CCC status Patient Finbarr Crotty, undergoing lung cancer treatment, personifies required rigorous The accreditation culminates nearly a decade of collaboration between evaluation across four St James’s and Trinity, building upon Trinity St James’s initial OECI integrated and patient- accreditation as Ireland’s first Cancer focused pillars Centre in 2019. The elevated CCC status required rigorous evaluation across four integrated and patient- focused pillars: pioneering cancer research, science-led treatments, new clinical trials and innovative education of the next generation of cancer leaders. As Minister Carroll MacNeill emphasised: ‘This milestone marks a significant advancement in cancer care for Ireland. Trinity St James’s ethos: ‘Patients like me are proactively involved in developing care and research. I contribute not just to my own care, but to improving others’ experiences.’ His testimony echoes the OECI’s praise for Trinity St James’s compassionate, collaborative model. The institute’s Patient Representative Group participated actively in the accreditation celebration alongside clinicians, researchers, and HSE leaders, symbolising the shared ownership of this achievement. Comprehensive Cancer Centres like Trinity St James’s As Ireland’s sole CCC, Trinity St James’s is now shouldering expand treatment options through research and training.’ dual responsibilities: advancing cutting-edge oncology The OECI specifically lauded Trinity St James’s exceptional nationally while collaborating with the more than 40 CCCs organisation of supportive care, including palliative and across Europe to share best practices. CEO, Professor Mary survivorship programmes, which o en challenge cancer Day highlighted this dual impact: ‘We are among Europe’s centres globally. These elements, noted the evaluators, premier cancer centres, benefiting patients and sta are seamlessly embedded at the heart of Trinity St James’s through continuous education and innovation networks.’ patient-centred model. Trinity St James’s traces its roots to 2016, when Trinity and CCC designation transcends ceremonial recognition, St James’s Hospital committed to integrating ‘ground- directly enhancing clinical outcomes. Patients treated breaking science with patient-focused clinical care’. With at comprehensive centres typically experience higher CCC status secured, Professor Maeve Lowery looks forward survival rates through coordinated multidisciplinary care, to ‘driving forward innovation in cancer research and psychological support, and earlier access to clinical trials. translating new findings into improvements in patient- According to Professor John Kennedy, Trinity St James’s centred cancer care.’ Medical Director, ‘Patients can be confident that the care they receive has been evaluated by international experts and found to be of the highest quality’. The institute’s As Minister Carroll MacNeill concluded, ‘I look forward to this institution’s continued impact on patient lives. integrated approach ensures research breakthroughs rapidly transition from laboratory to bedside, a synergy highlighted by Provost, Dr Linda Doyle, ‘The OECI accreditation recognises the close integration of research with clinical practice, allowing quick adaptation of advances This achievement exemplifies Trinity’s capacity to transform public health through academic leadership – proving that when world-class research converges with compassionate care, hope becomes institutional reality.’ for patient benefit.’
Download PDF file